Yongjun Cao Selected Research

gulose

12/2021

A gulose moiety contributes to the belomycin (BLM) disaccharide selective targeting to lung cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yongjun Cao Research Topics

Disease

26	Ischemic Stroke 06/2022 - 08/2015
19	Stroke (Strokes) 10/2022 - 07/2013
10	Cerebral Hemorrhage 01/2021 - 01/2016
5	Atherosclerosis 01/2022 - 11/2013
4	Pneumonia (Pneumonitis) 01/2022 - 02/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 10/2016
2	Neoplasms (Cancer) 12/2021 - 08/2014
2	Inflammation (Inflammations) 12/2021 - 01/2017
2	Brain Ischemia (Cerebral Ischemia) 04/2021 - 01/2021
2	Hypertension (High Blood Pressure) 04/2020 - 08/2015
2	Hematoma 01/2019 - 01/2018
2	Hemorrhage 01/2019 - 04/2016
2	Heart Failure 01/2018 - 04/2016
1	Eagle syndrome 10/2022
1	Atrial Fibrillation 06/2022
1	Alzheimer Disease (Alzheimer's Disease) 03/2022
1	Nervous System Diseases (Neurological Disorders) 03/2022
1	Cognitive Dysfunction 03/2022
1	Infarction (Infarctions) 02/2022
1	Lung Neoplasms (Lung Cancer) 12/2021
1	Intracranial Embolism 08/2021
1	Rheumatoid Arthritis 06/2021
1	Reperfusion Injury 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Anemia 01/2020
1	Thyroiditis 01/2020
1	Atrophy 01/2019
1	Coronary Disease (Coronary Heart Disease) 12/2018
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2016
1	Chronic Renal Insufficiency 07/2016
1	Body Weight (Weight, Body) 06/2016
1	Necrosis 01/2015
1	Neuroinflammatory Diseases 10/2014
1	Dyslipidemias (Dyslipidemia) 02/2014
1	Snoring 02/2014
1	Obstructive Sleep Apnea 02/2014
1	Atherosclerotic Plaque (Atheroma) 11/2013

Drug/Important Bio-Agent (IBA)

7	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2022 - 04/2016
6	oxidized low density lipoproteinIBA 04/2020 - 02/2014
4	HDL CholesterolIBA 12/2021 - 10/2016
3	LipidsIBA 01/2021 - 04/2020
3	LDL CholesterolIBA 01/2021 - 10/2016
3	Therapeutic UsesIBA 01/2021 - 01/2020
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 07/2013
2	C-Type Lectins (C-Type Lectin)IBA 04/2021 - 12/2018
2	Fibrinogen (Factor I)FDA Link 10/2020 - 11/2013
2	C-Reactive ProteinIBA 04/2020 - 01/2018
2	Blood Glucose (Blood Sugar)IBA 02/2019 - 04/2016
2	MagnesiumIBA 01/2019 - 01/2017
2	Cystatin CIBA 01/2019 - 01/2016
2	Phosphates (Orthophosphate)IBA 01/2018 - 04/2016
1	Pharmaceutical PreparationsIBA 10/2022
1	Long Noncoding RNAIBA 03/2022
1	Competitive Endogenous RNAIBA 03/2022
1	Antisense RNA (Anti-Sense RNA)IBA 03/2022
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Mitochondrial DNA (mtDNA)IBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Coloring Agents (Dyes)IBA 12/2021
1	DisaccharidesIBA 12/2021
1	guloseIBA 12/2021
1	Ketone BodiesIBA 10/2021
1	AnticoagulantsIBA 08/2021
1	DiosgeninIBA 06/2021
1	LigandsIBA 04/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	CholesterolIBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	Apolipoproteins AIBA 04/2020
1	Apolipoproteins B (ApoB)IBA 04/2020
1	HomocysteineIBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Alkaline PhosphataseIBA 01/2018
1	Bile Acids and Salts (Bile Acids)IBA 01/2018
1	Urea (Carbamide)FDA LinkGeneric 01/2018
1	NitrogenIBA 01/2018
1	HDL LipoproteinsIBA 01/2017
1	CreatinineIBA 07/2016
1	CalciumIBA 04/2016
1	Warfarin (Coumadin)FDA LinkGeneric 04/2016
1	ORALIT (ORS)IBA 01/2016
1	Uric Acid (Urate)IBA 08/2015
1	sodium bisulfide (NaHS)IBA 10/2014
1	AMP-Activated Protein KinasesIBA 10/2014
1	5- (4- hydroxyphenyl)- 3H- 1,2- dithiole- 3- thioneIBA 10/2014
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2014
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 02/2014
1	Messenger RNA (mRNA)IBA 11/2013
1	Matrix Metalloproteinases (MMPs)IBA 11/2013
1	FibrinIBA 11/2013

Therapy/Procedure

4	Thrombectomy 02/2022 - 01/2021
4	Therapeutics 12/2021 - 08/2015
3	Thrombolytic Therapy 08/2020 - 06/2016
1	Length of Stay 01/2021
1	Immunotherapy 01/2020
1	Aftercare (After-Treatment) 04/2016
1	Radiotherapy 08/2014